Who invested in Areteia Therapeutics?
Areteia Therapeutics's investors include Google Ventures, ARCH Venture Partners, Sanofi and Bain Capital Life Sciences.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$75Mraised across 1 round since 2024, from 1 source
Source recordedSEC filing: $275M sold, first sale Jun 2022
Areteia Therapeutics's investors include Google Ventures, ARCH Venture Partners, Sanofi and Bain Capital Life Sciences.
Areteia Therapeutics has raised $75M across 1 round since 2024.
Areteia Therapeutics's most recent round was a Series A of $75M in Feb 2024.
Its most recent round, $75M in Feb 2024, is also its largest on record.
Areteia Therapeutics's first round on record, in Feb 2024, was backed by Google Ventures, ARCH Venture Partners and Sanofi and 1 others.
Areteia Therapeutics's latest named round is a Series A, in Feb 2024.
Areteia Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.